LENSAR, Inc. Files Amendment No. 1 to Form 10-K: Key Points for Investors

Overview

LENSAR, Inc. (“the Company”, Nasdaq: LNSR) has filed Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This amendment was necessitated by a delay in filing the definitive proxy statement for the 2026 annual meeting of stockholders, resulting in the inclusion of critical Part III information directly in this amended filing.

Key Points in the Report

• Amendment Details:
  • The original Form 10-K filed on March 31, 2026, omitted portions of Part III (Items 10-14), relying on incorporation by reference from the proxy statement. Because the proxy will not be filed within 120 days of year-end, this Amendment No. 1 includes the full Part III content.
  • The amendment also updates certifications for the principal executive and financial officers as required by SEC rules.
  • No financial statements are included in this amendment, so Sarbanes-Oxley Section 906 certifications are not provided.
• Company Profile and Market Information:
  • LENSAR is not a well-known seasoned issuer, nor an emerging growth company or shell company.
  • As of June 30, 2025, the market value of LENSAR’s common stock held by non-affiliates was \$113.3 million.
  • As of April 28, 2026, there were 12,104,328 shares of common stock outstanding.
• Corporate Governance and Compliance:
  • The Company has adopted a comprehensive Code of Conduct and Insider Trading Compliance Policy, available online and filed as an exhibit.
  • LENSAR’s Audit Committee consists entirely of independent directors, each qualifying as an audit committee financial expert under SEC rules.
  • Section 16(a) compliance: All but two directors/officers (Ms. Wong and Mr. Staab) filed reports on time; each had one late Form 4 covering a single transaction.
• Executive Compensation Highlights:
  • Summary Compensation Table for 2024 and 2025 provides full details for named executive officers. Notably, CEO Nicholas T. Curtis received total compensation of \$2,344,966 in 2025.
  • Annual base salaries for executives were increased effective February 17, 2025, to remain competitive and retain talent.
  • Annual bonuses for 2025 were paid at target, approved by the Board in March 2026.
  • Outstanding equity awards and stock options for executives are disclosed in detail, reflecting the Company’s commitment to equity-based incentives.
  • Definitions for “Cause” and “Good Reason” in executive employment contracts are specified, offering clarity on termination scenarios.
• Board and Committee Structure:
  • Audit Committee: Dr. Link, Dr. Lindstrom, Ms. O’Farrell (chair), and Mr. Winer.
  • All audit committee members are financially literate and independent.
  • No family relationships among directors and executive officers.
• Legal and Regulatory Matters:
  • No indication of restatements or corrections to prior financial statements that would trigger compensation clawback analysis.
  • No auditor attestation of internal controls as required under Section 404(b) of Sarbanes-Oxley (Company is not a large accelerated filer).

Important for Shareholders & Potential Price Sensitivity

• Delayed Proxy Statement Filing: The inability to file the proxy statement within 120 days may signal internal or procedural delays, possibly affecting investor confidence. However, the Company has proactively addressed this by amending its 10-K.
• Executive Compensation Changes: Increases to base salaries and payment of annual bonuses at target may impact future cash flows and signal management’s confidence in performance targets.
• Board Independence & Governance: Strong governance, independent audit committee, and compliance policies are positive for long-term investor risk management.
• Market Value & Share Count: Public float and outstanding share numbers are crucial for valuation and liquidity analysis. The current market value of \$113.3 million and share count of 12,104,328 are up-to-date metrics for investors.
• No Financial Restatements or Clawback Issues: The absence of restatements or clawbacks is reassuring, indicating stable financial reporting.

Summary

The filing of Amendment No. 1 to Form 10-K is principally a procedural action to ensure compliance with SEC rules due to the delayed proxy statement. The amendment provides full transparency on corporate governance, executive compensation, and audit committee details. Investors should note increased executive compensation and robust governance practices. While no major negative developments are disclosed, the delay in proxy statement filing and increased executive pay may be watched closely by shareholders for any future impact on share value or investor sentiment.

Disclaimer

This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult professional advisors before making investment decisions. The information presented is based on the Company’s SEC filings and may be subject to further updates or corrections.

View LENSAR, Inc. Historical chart here